Paul Silva - Vertex Pharmaceuticals Insider

Vertex Pharmaceuticals Incorporated -- USA Stock  

USD 157.89  8.01  4.83%

Senior Vice President Corporate Controller

Mr. Paul M. Silva is Senior Vice President and Corporationrationrate Controller of Vertex Pharmaceuticals Incorporated. Mr. Silva is our Senior Vice President and Corporationrationrate Controller, a position he has held since April 2011. Mr. Silva joined us in August 2007 as Senior Director, Accounting Operations and was our Vice President and Corporationrationrate Controller from September 2008 through April 2011. Prior to joining us, he was the Vice President, Internal Reporting at Iron Mountain Incorporated from July 2006 until August 2007 and a consultant to Iron Mountains financing department from April 2005 until July 2006. He was the Finance Director of the Bioscience Technologies Division of Thermo Electron Corporationrationration from 2002 to April 2005
Age: 50  President Since 2011      
617-341-6100  http://www.vrtx.com
Silva holds a B.S. in accounting from Assumption College.

Paul Silva Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 10.73 % which means that it generated profit of $10.73 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 5.42 % meaning that it created $5.42 on every $100 dollars invested by stockholders.
The company currently holds 606.43 M in liabilities with Debt to Equity (D/E) ratio of 29.6 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Vertex Pharmaceuticals Incorporated has Current Ratio of 3.21 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Scott WhiteAbbott Laboratories
2013
Stephen FussellAbbott Laboratories
2013
Timothy ErnstBio Rad Laboratories Inc
2016
JeanYves PaveeAbbott Laboratories
2015
Robert StewartAllergan plc
N/A
Thomas FrinziAbbott Laboratories
2016
Georges VosAbbott Laboratories
2013
Heather MasonAbbott Laboratories
2015
Matthew MalettaEndo International plc
2015
Deepak NathAbbott Laboratories
2015
John HertiaBio Rad Laboratories Inc
2014
Michael CrowleyBio Rad Laboratories Inc
2014
Daniel RudioEndo International plc
N/A
Brian LortieEndo International plc
N/A
Terrance CoughlinEndo International plc
2016
Murthy SimhambhatlaAbbott Laboratories
2013
Joseph ManningAbbott Laboratories
2017
Michael WarmuthAbbott Laboratories
2012
Charles FoltzAbbott Laboratories
2013
Antonio PeraEndo International plc
2016
Blaise ColemanEndo International plc
2016

Entity Summary

Vertex Pharmaceuticals Incorporated, a biotechnology company, develops medicines for serious diseases. The company was founded in 1989 and is headquartered in Boston, Massachusetts. Vertex Pharmaceuticals operates under Biotechnology classification in USA and traded on NASDAQ exchange. It employs 2300 people.Vertex Pharmaceuticals Incorporated (VRTX) is traded on NASDAQ in USA. It is located in MASSACHUSETTS, U.S.A and employs 2,300 people. Vertex Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Vertex Pharmaceuticals Incorporated to your portfolio

Top Management

Vertex Pharmaceuticals Leadership Team
Paul Silva, President
William Young, Director, MBA
David Altshuler, Director
Jeffrey Chodakewitz, President
Elaine Ullian, Director
Michael Parini, President
Alan Garber, Director, Ph.D
Amit Sachdev, President
Joshua Boger, Chairman
David Greenway, Director
Bruce Sachs, Director, MBA
Margaret McGlynn, Director, MBA
Michael Partridge, President
Yuchun Lee, Director, MBA
Sangeeta Bhatia, Director, Ph.D
Stuart Arbuckle, EVP
Thomas Graney, President, MBA
Terrence Kearney, Director, MBA
Ian Smith, President
Jeffrey Leiden, Chairman, Ph.D

Stock Performance

Vertex Pharmaceuticals Performance Indicators